UCSC Genome Browser and BRCA Exchange: Data Resources for Clinical Variant Interpretation
Join Drs. Maximilian Haeussler and Melissa Cline from the University of California Santa Cruz (UCSC) Genomics Institute as they discuss data resources for clinical variant interpretation within their UCSC programs.
Dr. Haeussler is the co-principal investigator for UCSC Genome Browser, which offers access to genome sequence data from a variety of vertebrate and invertebrate species, and major model organisms.
Dr. Cline is the program manager of the UCSC BRCA Exchange, an open-source data repository sponsored by NCI and NIH. It’s designed to advance the understanding of the genetic basis of breast, ovarian, pancreatic, and other cancers by pooling data on BRCA1/2 genetic variants and corresponding clinical data from around the world.
This presentation is a part of the Sequencing Strategies for Population and Cancer Epidemiology Studies (SeqSPACE) webinar series. Hosted by NCI’s Epidemiology and Genomics Research Program, this series provides an opportunity for NCI grantees and other interested individuals to share lessons learned and information regarding the application of next generation sequencing to cancer epidemiology studies.
Dr. Haeussler the co-principal investigator for the UCSC Genome Browser. He works on single-cell visualization and has interests in biomedical text mining and genome annotation.
Dr. Cline is an associate research scientist at the UCSC Genomics Institute and the program manager of the BRCA Exchange. She leads a team of software engineers and graduate students to pioneer methods for sharing genetic data.
Upcoming Events
- Leveraging Optical Imaging and Data Science to Enable Precision Intervention in Brain Tumor SurgeryNovember 26, 2024Evaluating AI Models: Benchmarking and FairnessNovember 26, 20242024 U.S. Southeast Healthcare Innovation SummitDecember 04, 2024Molecular Characterization Initiative (MCI) Update: Pediatric Soft Tissue SarcomasDecember 10, 2024AI-Foundational Models for Cancer Imaging BiomarkersDecember 17, 2024